Hereditary angioedema is a rare autosomal dominant disorder and has disease epidemiology of one individual per 10,000 - 50,000 without major sex or ethnic differences.
This report elaborates the market size, market characteristics, and market growth of the Hereditary Angioedema industry, and breaks down according to the type, application, and consumption area of Hereditary Angioedema. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Hereditary Angioedema in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Hereditary Angioedema market covered in Chapter 13:
Merck & Co., Inc.
Sanofi N.V.
CSL
iBio
Teva Pharmaceutical Industries
Cipla, Inc.
ioCryst Pharmaceuticals
Shire
Ionis Pharmaceuticals
Pharming Group
In Chapter 6, on the basis of types, the Hereditary Angioedema market from 2015 to 2025 is primarily split into:
Type I HAE
Type II HAE
Type III HAE
In Chapter 7, on the basis of applications, the Hereditary Angioedema market from 2015 to 2025 covers:
Hospitals
clinics
Research centers
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025